Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain.

Por Webster, M K, Donoghue, D J
Publicado em 1997

Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.

Por Webster, M K, Donoghue, D J
Publicado em 1996

Profound ligand-independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysp...

Por Webster, M K, D'Avis, P Y, Robertson, S C, Donoghue, D J
Publicado em 1996

Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum.

Por Webster, M K, Goya, L, Ge, Y, Maiyar, A C, Firestone, G L
Publicado em 1993

Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.

Por Galvin, B D, Hart, K C, Meyer, A N, Webster, M K, Donoghue, D J
Publicado em 1996

Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.

Por Meyer, A N, Xu, Y F, Webster, M K, Smith, A E, Donoghue, D J
Publicado em 1994

A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene.

Por Tavormina, P L, Bellus, G A, Webster, M K, Bamshad, M J, Fraley, A E, McIntosh, I, Szabo, J, Jiang, W, Jabs, E W, Wilcox, W R, Wasmuth, J J, Donoghue, D J, Thompson, L M, Francomano, C A
Publicado em 1999